Jay T. Rubinstein, MD, PhD, highlighted promising CHORD trial data showing that DB-OTO gene therapy has led to hearing improvements in treated participants.
Jay Rubinstein, MD, PhD
Advertisement
Articles by Jay Rubinstein, MD, PhD
Advertisement
Latest Updated Articles
Jay Rubinstein, MD, PhD, explains DB-OTO gene therapy in children with profound hearing lossPublished: March 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
2
Health system–based clinical pathway improves pediatric lipid screening rates
3
Silvana Bonilla, MD, discusses geographic patterns of H. Pylori in pediatric digestive disease
4
Prenatal COVID-19 exposure linked to adverse neurodevelopment in offspring
5
